CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lukaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 酒石酸伐尼克兰Varenicline Tartrate
Varenicline Tartrate

酒石酸伐尼克兰 杂质对照品Varenicline Tartrate Impurities

37 个杂质条目37 impurity entries

本页汇总 酒石酸伐尼克兰 的 37 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 37 impurity reference standards of Varenicline Tartrate. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 酒石酸伐尼克兰(Varenicline Tartrate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStress degradation studies on varenicline tartrate and development of a validated stability-indicating HPLC method
    Scientia pharmaceutica · 2012 · Pujeri SS et al.  ·  PMID 22396908  ·  DOI
  2. 杂质研究Impurity studiesImpurity profiling of varenicline tartrate by LC-QTOF mass spectrometric techniques during drug development
    Journal of pharmaceutical and biomedical analysis · 2018 · Lu Y et al.  ·  PMID 29679875  ·  DOI
  3. 杂质研究Impurity studiesStability Assessment of FDA Approved Varenicline Tartrate Products for Critical Quality Attributes - N-Nitroso Varenicline, Solid Form, and Dissolution
    AAPS PharmSciTech · 2026 · Hassan MA et al.  ·  PMID 41957248  ·  DOI
  4. 杂质研究Impurity studiesNovel liquid chromatographic methods for the determination of varenicline tartrate
    Talanta · 2016 · El-Bagary RI et al.  ·  PMID 26695238  ·  DOI
  5. 杂质研究Impurity studiesN-methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet
    Journal of pharmaceutical sciences · 2008 · Waterman KC et al.  ·  PMID 17879378  ·  DOI

酒石酸伐尼克兰 —— 原料药与杂质对照品Varenicline Tartrate — drug substance & impurities

共 37 个条目(含原料药本体)37 items incl. the drug substance
Varenicline structure
—
伐尼克兰Varenicline
Varenicline
CAS No.249296-44-4
Chemical FormulaC13H13N3
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline L-Tartrate structure
—
L-酒石酸伐尼克兰Varenicline L-Tartrate
Varenicline L-Tartrate
CAS No.375815-87-5
Chemical FormulaC13H13N3·C4H6O6
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Citrate structure
—
柠檬酸伐尼克兰Varenicline Citrate
Varenicline Citrate
CAS No.536696-70-5
Chemical FormulaC13H13N3·C6H8O7
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 8 structure
8
酒石酸伐尼克兰杂质8Varenicline Tartrate Impurity 8
Varenicline Tartrate Impurity 8
CAS No.796865-82-2
Chemical FormulaC14H13N3O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 12 structure
12
酒石酸伐尼克兰杂质12Varenicline Tartrate Impurity 12
Varenicline Tartrate Impurity 12
CAS No.1333145-89-3
Chemical FormulaC14H15N3
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 13 structure
13
酒石酸伐尼克兰杂质13Varenicline Tartrate Impurity 13
Varenicline Tartrate Impurity 13
CAS No.357424-21-6
Chemical FormulaC13H13N3O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 15 structure
15
酒石酸伐尼克兰杂质15Varenicline Tartrate Impurity 15
Varenicline Tartrate Impurity 15
CAS No.2306217-12-7
Chemical FormulaC13H13N3O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 16 structure
16
酒石酸伐尼克兰杂质16Varenicline Tartrate Impurity 16
Varenicline Tartrate Impurity 16
CAS No.1350219-74-7
Chemical FormulaC13H13N3O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 18 structure
18
酒石酸伐尼克兰杂质18Varenicline Tartrate Impurity 18
Varenicline Tartrate Impurity 18
CAS No.1337563-47-9
Chemical FormulaC13H13N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 19 structure
19
酒石酸伐尼克兰杂质19Varenicline Tartrate Impurity 19
Varenicline Tartrate Impurity 19
CAS No.230615-70-0
Chemical FormulaC15H12F3N3O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 20 structure
20
酒石酸伐尼克兰杂质20Varenicline Tartrate Impurity 20
Varenicline Tartrate Impurity 20
CAS No.950781-87-0
Chemical FormulaC11H13N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 25 structure
25
酒石酸伐尼克兰杂质25Varenicline Tartrate Impurity 25
Varenicline Tartrate Impurity 25
CAS No.230615-69-7
Chemical FormulaC13H14F3N3O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 31 structure
31
酒石酸伐尼克兰杂质31Varenicline Tartrate Impurity 31
Varenicline Tartrate Impurity 31
CAS No.230615-83-5
Chemical FormulaC13H12F3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 32 structure
32
酒石酸伐尼克兰杂质32Varenicline Tartrate Impurity 32
Varenicline Tartrate Impurity 32
CAS No.357426-10-9
Chemical FormulaC15H12F3N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 33 structure
33
酒石酸伐尼克兰杂质33Varenicline Tartrate Impurity 33
Varenicline Tartrate Impurity 33
CAS No.950781-91-6
Chemical FormulaC11H15N3
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 34 structure
34
酒石酸伐尼克兰杂质34Varenicline Tartrate Impurity 34
Varenicline Tartrate Impurity 34
CAS No.2724982-86-7
Chemical FormulaC13H13N3O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 36 structure
36
酒石酸伐尼克兰杂质36Varenicline Tartrate Impurity 36
Varenicline Tartrate Impurity 36
CAS No.230615-59-5
Chemical FormulaC13H10F3N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 37 (N-Nitroso Varenicline) structure
37
酒石酸伐尼克兰杂质37 (N-亚硝基伐尼克兰)Varenicline Tartrate Impurity 37 (N-Nitroso Varenicline)
Varenicline Tartrate Impurity 37 (N-Nitroso Varenicline)
CAS No.2755871-02-2
Chemical FormulaC13H12N4O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 38 structure
38
酒石酸伐尼克兰杂质38Varenicline Tartrate Impurity 38
Varenicline Tartrate Impurity 38
CAS No.1329651-19-5
Chemical FormulaC20H16N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 39 structure
39
酒石酸伐尼克兰杂质39Varenicline Tartrate Impurity 39
Varenicline Tartrate Impurity 39
CAS No.873302-30-8
Chemical FormulaC13H11N3O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 40 structure
40
酒石酸伐尼克兰杂质40Varenicline Tartrate Impurity 40
Varenicline Tartrate Impurity 40
CAS No.873302-31-9
Chemical FormulaC19H23N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 41 structure
41
酒石酸伐尼克兰杂质41Varenicline Tartrate Impurity 41
Varenicline Tartrate Impurity 41
CAS No.535920-98-0
Chemical FormulaC20H21N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 42 structure
42
酒石酸伐尼克兰杂质42Varenicline Tartrate Impurity 42
Varenicline Tartrate Impurity 42
CAS No.230615-08-4
Chemical FormulaC11H11N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 43 structure
43
酒石酸伐尼克兰杂质43Varenicline Tartrate Impurity 43
Varenicline Tartrate Impurity 43
CAS No.950781-94-9
Chemical FormulaC11H11N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 44 structure
44
酒石酸伐尼克兰杂质44Varenicline Tartrate Impurity 44
Varenicline Tartrate Impurity 44
CAS No.950781-89-2
Chemical FormulaC13H12F3N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 45 structure
45
酒石酸伐尼克兰杂质45Varenicline Tartrate Impurity 45
Varenicline Tartrate Impurity 45
CAS No.2306217-11-6
Chemical FormulaC13H13N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 47 structure
47
酒石酸伐尼克兰杂质47Varenicline Tartrate Impurity 47
Varenicline Tartrate Impurity 47
CAS No.328055-92-1
Chemical FormulaC14H15N3
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 66 structure
66
酒石酸伐尼克兰杂质66Varenicline Tartrate Impurity 66
Varenicline Tartrate Impurity 66
CAS No.1213781-59-9
Chemical FormulaC15H15N3O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 67 (N-Nitroso Varenicline Tartrate Impurity 42) structure
67
酒石酸伐尼克兰杂质67 (N-亚硝基酒石酸伐尼克兰杂质42)Varenicline Tartrate Impurity 67 (N-Nitroso Varenicline Tartrate Impurity 42)
Varenicline Tartrate Impurity 67 (N-Nitroso Varenicline Tartrate Impurity 42)
CAS No.2803960-63-4
Chemical FormulaC11H10N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 69 structure
69
酒石酸伐尼克兰杂质69Varenicline Tartrate Impurity 69
Varenicline Tartrate Impurity 69
CAS No.87-91-2
Chemical FormulaC8H14O6
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 73 structure
73
酒石酸伐尼克兰杂质73Varenicline Tartrate Impurity 73
Varenicline Tartrate Impurity 73
CAS No.69718-76-9
Chemical FormulaC11H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 76 (N-Nitroso Varenicline Tartrate Impurity 75) structure
76
酒石酸伐尼克兰杂质76 (N-亚硝基酒石酸伐尼克兰杂质75)Varenicline Tartrate Impurity 76 (N-Nitroso Varenicline Tartrate Impurity 75)
Varenicline Tartrate Impurity 76 (N-Nitroso Varenicline Tartrate Impurity 75)
CAS No.2803960-64-5
Chemical FormulaC11H14N4O
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 85 Hydrochloride structure
85
酒石酸伐尼克兰杂质85 盐酸盐Varenicline Tartrate Impurity 85 Hydrochloride
Varenicline Tartrate Impurity 85 Hydrochloride
CAS No.230615-05-1
Chemical FormulaC11H14N2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 85 structure
85
酒石酸伐尼克兰杂质85Varenicline Tartrate Impurity 85
Varenicline Tartrate Impurity 85
CAS No.2705927-79-1
Chemical FormulaC11H14N2·C2H2O4
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 85 Monomer structure
85
酒石酸伐尼克兰杂质85 单体Varenicline Tartrate Impurity 85 Monomer
Varenicline Tartrate Impurity 85 Monomer
CAS No.357424-22-7
Chemical FormulaC11H14N2
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 86 structure
86
酒石酸伐尼克兰杂质86Varenicline Tartrate Impurity 86
Varenicline Tartrate Impurity 86
CAS No.230615-53-9
Chemical FormulaC13H11F3N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Varenicline Tartrate Impurity 87 structure
87
酒石酸伐尼克兰杂质87Varenicline Tartrate Impurity 87
Varenicline Tartrate Impurity 87
CAS No.853946-18-6
Chemical FormulaC13H10F3N3O5
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

酒石酸伐尼克兰 —— 研究文献与合成路线Varenicline Tartrate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 酒石酸伐尼克兰 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Varenicline Tartrate. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stress degradation studies on varenicline tartrate and development of a validated stability-indicating HPLC method
    Pujeri SS, Khader AM, Seetharamappa J · Scientia pharmaceutica · 2012 · 被引 2cited 2
  2. Impurity profiling of varenicline tartrate by LC-QTOF mass spectrometric techniques during drug development
    Lu Y, Sun X, Song F, et al. · Journal of pharmaceutical and biomedical analysis · 2018 · 被引 5cited 5

合成与制备工艺专利Synthesis & process patents

  1. AMORPHOUS VARENICLINE TARTRATE AND PROCESS FOR THE PREPARATION THEREOF
    KHAN MUBEEN AHMED · 公开号 US2009318460US2009318460 · 2009
  2. Preparations of new polymorphic forms of varenicline tartrate
    GU HUANG CAI, HE HUANG HUI MIN · 公开号 CN101851236CN101851236 · 2010
  3. Preparations of new polymorphic forms of varenicline tartrate
    HUANG CAI GU, HUANG HUI MIN HE · 公开号 US2009215787US2009215787 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

酒石酸伐尼克兰 杂质谱研究要点Varenicline Tartrate — impurity profiling notes

下面这些是拿到 酒石酸伐尼克兰 的 37 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 37 impurity entries for Varenicline Tartrate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances